Published date: 17 March 2022

Last edited date: 2 July 2022

Open future opportunity - This means that the buyer is not yet ready to invite bid applications but early notification has been provided and some dialogue may be possible.


Approach to market date: 1 December 2024

Contract summary

Industry

  • Albumin - 33141540

Location of contract

England, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£30,000,000

Procurement reference

CM/PHS/22/5652/W

Published date

17 March 2022

Approach to market date

1 December 2024

Contract start date

1 May 2025

Contract end date

31 October 2026

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Human Albumin

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2025/2026 £18,333,333
2026/2027 £11,666,667

How to apply

Follow the instructions given in the description or the more information section.

About the buyer

Contact name

Jennifer Tierney

Address

Commercial Medicines Unit - NHS England
2nd Floor, Rutland House
Runcorn
WA7 2AS
England

Email

jennifer.tierney@nhs.net